Spectrum Pharmaceuticals, Inc. (SPPI) Stock Analysis
DELISTED 2023
What happened to Spectrum Pharmaceuticals, Inc. (SPPI) stock?
Spectrum Pharmaceuticals, Inc. (SPPI) no longer trades on public markets. It was delisted in July 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- July 2023
- Last recorded price (historical):
- $1.03 (last quote on record before the July 2023 delisting; historical, not a current quote)
Market cap $210M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Spectrum Pharmaceuticals, Inc. (SPPI). Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing oncology and hematology drug products. Their pipeline includes treatments for chemotherapy-induced neutropenia and non-small cell lung cancer.
Last analyzed: May 9, 2026Spectrum Pharmaceuticals, Inc. (SPPI) Healthcare & Pipeline Overview
More about this archive record
Can I still buy SPPI shares?
No. SPPI stopped trading on public markets in July 2023, so the shares are not available through a broker. Anything you see quoted for SPPI elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SPPI stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Spectrum Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.